Skip to content

Study on the effect of TCM TEAS on the prevention and treatment of PONV after gynecological laparoscopic surgery

Study on the effect of TCM TEAS on the prevention and treatment of PONV after gynecological laparoscopic surgery

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300073103
Enrollment
Unknown
Registered
2023-06-30
Start date
2023-07-02
Completion date
Unknown
Last updated
2023-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nausea and vomiting after general anesthesia

Interventions

TEAS group:30min before anesthesia, the percutaneous acupuncture points were continuously given to the acupuncture points of Jinghegu, Neiguan, Zusanli and Sanyin until the end of the operation.
Control group:The patient was given a sham acupuncture 30min before anesthesia (1cm to take the acupoint next to Hegu, Neiguan, Zusanli and Sanyinjiao, connected to the stimulator, and no electrical s

Sponsors

Shanghai Tongren Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients undergoing elective gynecological laparoscopic surgery under general anesthesia (1) Patients hospitalized for laparoscopic gynecological surgery; (2) Preoperative general condition can be, ASA grade I ~ III; Age 18-65 years old (3) patients can communicate normally, there are no obvious contraindications to acupuncture; (4) The skin of the limbs is intact, suitable for acupuncture; (5) The patient and family sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Patients with gastrointestinal motor dysfunction caused by other causes before surgery; (2) Psychopaths; (3) Pregnant and lactating patients; (4) Those who have used drugs to promote gastrointestinal motility before surgery, domperidone, mosapride, cisapride ; (5) Those who have injury or infection at the needle puncture site; (6) Those who have participated in other clinical trials, or those who have participated in other clinical trials and have not completed 1 month

Design outcomes

Primary

MeasureTime frame
Postoperative nausea and vomiting;

Secondary

MeasureTime frame
C-reactive protein;Interleukin-6;Interleukin -10 ;Tumor necrosis factor-a;creatine kinase;

Countries

China

Contacts

Public ContactZhang Guang Ming

Shanghai Tongren Hospital

zhupei19900904@163.com+86 181 2122 6630

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026